Illumina, Inc Patent Portfolio Statistics

Illumina, Inc

Illumina, Inc`s Profile

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Illumina, Inc look like?

Total Applications:	23
Granted Patents:	20
Grant Index	86.96 %
Abandoned/Rejected Applications:	3 (13.04%)
In-Process Applications:	0
Average Grant Time:	2.6 Years
Average Office Actions:	1.9

Which Technology Area Illumina, Inc is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
1634	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	4
1636	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	3
1639	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	3
1798	Food, Miscellaneous Articles, Stock marterial	2
2872	Optics	2

How many patents are Illumina, Inc filing every year?

Year	Total Applications
2022	0*
2021	0*
2020	0
2019	1
2018	0

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Illumina, Inc in USPTO?

Publication number: –

Abstract:
None

Publication date: –
Applicant: Illumina, Inc
Inventors: A Andrew Brown

Publication number: US20220003728A1

Abstract:
An apparatus includes a flow cell body, a plurality of electrodes, an imaging assembly, and one or more barrier features. The flow cell body defines one or more flow channels and a plurality of wells defined as recesses in the floor of each flow channel. Each well is fluidically coupled with the corresponding flow channel. The flow cell body further defines interstitial surfaces between adjacent wells. Each well defines a corresponding depth. Each electrode is positioned in a corresponding well of the plurality of wells. The electrodes are to effect writing of polynucleotides in the wells. The imaging assembly is to capture images of polynucleotides written in the wells. The one or more barrier features are positioned in the wells, between the wells, or above the wells. The one or more barrier features contain reactions in each well, reduce diffusion between the wells, or reduce optical cross-talk between the wells.

Publication date: 2022-01-06
Applicant: Illumina, Inc
Inventors: Aathavan Karunakaran

Publication number: US20220002791A1

Abstract:
A method for spatially tagging nucleic acids of a biological specimen, including steps of (a) providing a solid support comprising different nucleic acid probes that are randomly located on the solid support, wherein the different nucleic acid probes each includes a barcode sequence that differs from the barcode sequence of other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to locate the barcode sequences on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen; and (e) modifying the randomly located probes that are hybridized to the target nucleic acids, thereby producing modified probes that include the barcode sequences and a target specific modification, thereby spatially tagging the nucleic acids of the biological specimen.

Publication date: 2022-01-06
Applicant: Illumina, Inc
Inventors: Joakim Lundeberg

How are Illumina, Inc’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17599994	Kits And Flow Cells	–	–	–
17479342	Flow Cell With One Or More Barrier Features	Non Final Action Mailed	2886	Akanbi, Isiaka O
17479718	Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens	Non Final Action Mailed	1637	Thomas, David C
17470228	Obtaining Information From A Biological Sample In A Flow Cell	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17464417	Elongated Modular Heatsink With Coupled Light Source	Docketed New Case – Ready for Examination	OPAP	Central, Docket